SPY319.34+7.98 2.56%
DIA271.54+8.21 3.12%
IXIC9,814.08+198.27 2.06%
News
GMAB
--
0.00%
--
Genmab Reports European Marketing Authorization For Subcutaneous Formulation Of DARZALEX For Treatment Of Patients With Multiple Myeloma
Benzinga · 2d ago
Biotech ETFs Are Soaring. These Four Are Still Worth Considering.
Barrons.com · 5d ago
HC Wainwright & Co. Maintains Buy on Genmab, Raises Price Target to $34
HC Wainwright & Co. maintains Genmab (NASDAQ:GMAB) with a Buy and raises the price target from $29 to $34.
Benzinga · 5d ago
The Daily Biotech Pulse: ASCO Presentations Begin, Altimmune Pops On Insider Buying, Immutep Gets R&D Grant
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 28)
Benzinga · 05/29 11:22
Stocks That Hit 52-Week Highs On Thursday
During Thursday's morning trading, 73 companies set new 52-week highs.
Benzinga · 05/28 14:39
The Daily Biotech Pulse: Cumberland's Positive Anti-Bacterial Readout, FDA Nods For Bristol-Myers, Astellas
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 26)
Benzinga · 05/27 11:25
Stocks That Hit 52-Week Highs On Tuesday
On Tuesday, 118 companies set new 52-week highs.
Benzinga · 05/26 14:32
The Week Ahead In Biotech: ASCO Presentations In The Spotlight
Biotech stocks closed the week ended May 22 higher, with stray clinical readouts and COVID-19 drug- and vaccine-related news moving stocks in the sector.
Benzinga · 05/24 18:40
The Daily Biotech Pulse: Mixed Filgotinib Readout For Gilead-Galapagos, Akorn To File For Chapter 11, D-Day For Aquestive
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs on May 20.)
Benzinga · 05/21 12:01
Stocks That Hit 52-Week Highs On Wednesday
During Wednesday's morning session, 85 stocks hit new 52-week highs.
Benzinga · 05/20 14:38
Genmab's Shares March Higher, Can It Continue?
Zacks · 05/20 11:35
The Daily Biotech Pulse: FDA Nod For Roche, Arbutus Releases Positive Readout For HBV Therapy, Moderna Announces $1.34B Common Stock Offering
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 18)
Benzinga · 05/19 12:27
Stocks That Hit 52-Week Highs On Monday
During the morning session on Monday, 120 stocks hit new 52-week highs.
Benzinga · 05/18 14:44
Genmab Highlights Data To Be Presented At European Hematology Association Congress Jun. 11-14
Genmab A/S (NASDAQ:GMAB) announced today that eight industry sponsored abstracts regarding Genmab and partner programs were accepted for presentation at the 25th European Hematology Association (EHA) EHA25 Virtual
Benzinga · 05/14 13:42
The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 12)
Benzinga · 05/13 11:40
How Does Genmab's (CPH:GMAB) P/E Compare To Its Industry, After Its Big Share Price Gain?
Simply Wall St. · 05/13 05:48
Stocks That Hit 52-Week Highs On Tuesday
Tuesday morning saw 85 companies set new 52-week highs.
Benzinga · 05/12 14:41
Stocks That Hit 52-Week Highs On Friday
Friday's morning session saw 60 companies set new 52-week highs.
Benzinga · 05/08 14:32
SunTrust Robinson Humphrey Maintains Buy on Genmab, Raises Price Target to $30
SunTrust Robinson Humphrey maintains Genmab (NASDAQ:GMAB) with a Buy and raises the price target from $28 to $30.
Benzinga · 05/07 16:01
Genmab A/S (GMAB) Q1 2020 Earnings Call Transcript
Ladies and gentlemen, thank you for standing by, and welcome to Genmab's First Quarter Report 2020 Conference Call. Genmab is not under an obligation to update statements regarding the future nor to confirm such statements in relation to actual results, unles
Motley Fool · 05/07 14:00